These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7943629)

  • 1. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
    Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
    Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
    Radfar A; Stefanato CM; Ghosn S; Bhawan J
    Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characteristics of melanoma.
    Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
    J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions.
    Böni R; Burg G; Doguoglu A; Ilg EC; Schäfer BW; Müller B; Heizmann CW
    Br J Dermatol; 1997 Jul; 137(1):39-43. PubMed ID: 9274623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful?
    Karimipour DJ; Lowe L; Su L; Hamilton T; Sondak V; Johnson TM; Fullen D
    J Am Acad Dermatol; 2004 May; 50(5):759-64. PubMed ID: 15097961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
    Rohrbach JM; Steuhl KP; Thanos S
    Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of necrotic malignant melanomas.
    Nonaka D; Laser J; Tucker R; Melamed J
    Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase pi.
    Orlandi A; Costantini S; Campione E; Ferlosio A; Amantea A; Bianchi L; Chimenti S; Spagnoli LG
    Arch Dermatol; 2009 Jan; 145(1):55-62. PubMed ID: 19153344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34 expression in primary cutaneous malignant melanoma: apropos of a case and review of the aberrant melanoma phenotype.
    Breza TS; Magro CM
    J Cutan Pathol; 2005 Nov; 32(10):685-9. PubMed ID: 16293181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of XIAP in melanoma.
    Emanuel PO; Phelps RG; Mudgil A; Shafir M; Burstein DE
    J Cutan Pathol; 2008 Mar; 35(3):292-7. PubMed ID: 18251743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain.
    Kindblom LG; Lodding P; Rosengren L; Baudier J; Haglid K
    Acta Pathol Microbiol Immunol Scand A; 1984 Jul; 92(4):219-30. PubMed ID: 6496075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
    McCluggage WG; Bissonnette JP; Young RH
    Int J Gynecol Pathol; 2006 Oct; 25(4):321-9. PubMed ID: 16990706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
    Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.